Clinical trial
A Randomized, Single-Blind Pilot Study to Compare the Efficacy and Cost-Effectiveness of Frovatriptan vs. Topiramate for the Prevention of Migraine
NCT00846495 is registered in ClinicalTrials.gov with Clinvest as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized, Single-Blind Pilot Study to Compare the Efficacy and Cost-Effectiveness of Frovatriptan vs. Topiramate for the Prevention of Migraine
- Lead sponsor
- Clinvest
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- August 31, 2009
- Completion date
- January 31, 2011
- Enrollment
- 55 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
migraine